These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27756654)

  • 1. Interstitial lung disease caused by oxaliplatin. An uncommon but not unknown complication.
    Sánchez Cendra C; Juez Martel I; Gutierrez Abad D
    Arch Bronconeumol; 2017 Apr; 53(4):213-215. PubMed ID: 27756654
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.
    Gagnadoux F; Roiron C; Carrie E; Monnier-Cholley L; Lebeau B
    Am J Clin Oncol; 2002 Aug; 25(4):388-90. PubMed ID: 12151971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interstitial lung disease associated with combination chemotherapy of oxaliplatin, 5-fluorouracil, and leucovorin].
    Park S; Jung JJ; Kim GB; Yoon HS; Ko SH; Ko JE; Lee YS
    Korean J Gastroenterol; 2010 May; 55(5):340-3. PubMed ID: 20697195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
    Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
    Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
    [No Abstract]   [Full Text] [Related]  

  • 5. Interstitial lung disease associated with oxaliplatin: description of two cases.
    Pena Alvarez C; Suh Oh HJ; Sáenz de Miera Rodríguez A; García Arroyo FR; Covela Rúa M; Salgado Boquete L; López Clemente PM; Constenla Figueiras M
    Clin Transl Oncol; 2009 May; 11(5):332-3. PubMed ID: 19451069
    [No Abstract]   [Full Text] [Related]  

  • 6. Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report.
    Mitsuboshi S; Kozakai H; Yamada H; Nagai K; Furukawa T; Aizawa K
    J Oncol Pharm Pract; 2018 Oct; 24(7):540-543. PubMed ID: 28696176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence and management of adverse events in FOLFOX plus bevacizumab therapy for colorectal cancer].
    Shimodaira H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():582-6. PubMed ID: 25831827
    [No Abstract]   [Full Text] [Related]  

  • 8. Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
    Vargas A; Montironi C; Buxó E
    Arch Bronconeumol; 2015 Nov; 51(11):610. PubMed ID: 26163115
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 10. Interstitial lung disease during chemotherapy combined with oxaliplatin and/or bevacizumab in advanced colorectal cancer patients.
    Usui K; Katou Y; Furushima K; Tanaka Y; Tanai C; Ishihara T
    Jpn J Clin Oncol; 2011 Apr; 41(4):498-502. PubMed ID: 21303791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late anastomotic dehiscence during bevacizumab therapy for patients with colorectal cancer.
    Garant A; Des Groseilliers S; Martin L; Ferland É; Vuong T
    Clin Oncol (R Coll Radiol); 2011 Sep; 23(7):497-8. PubMed ID: 21576010
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute interstitial pneumonitis in a patient receiving a FOLFOX-4 regimen plus cetuximab treated with pulse therapy.
    Lai JI; Wang WS; Lai YC; Lin PC; Chang SC
    Int J Clin Pharmacol Ther; 2010 Jul; 48(7):425-8. PubMed ID: 20557834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of oxaliplatin and infusional fluorouracil/leucovorin (FOLFOX4) for Japanese patients with unresectable metastatic colorectal cancer.
    Fuse N; Doi T; Ohtsu A; Takeuchi S; Kojima T; Taku K; Tahara M; Muto M; Asaka M; Yoshida S
    Jpn J Clin Oncol; 2007 Jun; 37(6):434-9. PubMed ID: 17656481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standard chemotherapy for colonic neoplasms].
    Hyodo I
    Nihon Naika Gakkai Zasshi; 2007 Feb; 96(2):283-8. PubMed ID: 17370594
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
    Vargo CA; Blazer M; Reardon J; Gulati M; Bekaii-Saab T
    Clin Colorectal Cancer; 2016 Jun; 15(2):e61-3. PubMed ID: 26701613
    [No Abstract]   [Full Text] [Related]  

  • 16. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule.
    Schüll B; Kornek GV; Scheithauer W
    Ann Oncol; 2001 Nov; 12(11):1653-4. PubMed ID: 11822769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ambulatory chemotherapy schedule for metastatic colorectal cancer].
    Watine J; Soulage C
    Presse Med; 2001 Jan; 30(1):35. PubMed ID: 11210587
    [No Abstract]   [Full Text] [Related]  

  • 18. Fatal pneumonitis induced by oxaliplatin.
    Arévalo Lobera S; Sagastibeltza Mariñelarena N; Elejoste Echeberría I; Melé Olivé M; Egaña Otaño L; Basterretxea Badiola L; La Casta Muñoa A; Azkue Gabilondo M
    Clin Transl Oncol; 2008 Nov; 10(11):764-7. PubMed ID: 19015075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature.
    Cobo F; De Celis G; Pereira A; Latorre X; Pujadas J; Albiol S
    Anticancer Drugs; 2007 Sep; 18(8):973-6. PubMed ID: 17667605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N; Garay CA; Gurtler J; Hochster H; Kennedy P; Benson A; Brandt DS; Polikoff J; Wertheim M; Shumaker G; Hallman D; Burger B; Gupta S
    J Clin Oncol; 2004 Dec; 22(23):4753-61. PubMed ID: 15570076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.